Eli Lilly has expanded its relationship with Abbisko Therapeutics, committing up to $1.9 billion to get the Chinese biotech to apply its drug discovery and early development capabilities to multiple ...

When Dave Ricks became chief executive officer of Eli Lilly & Co. in 2017, he was facing an industry under siege. Americans held drug companies in lower esteem than airlines, law firms and even the ...

Indianapolis-based Eli Lilly and Company gave an unidentified 79-year-old man exclusive access to its experimental obesity and diabetes drug, according to reporting by the life sciences media ...

The FDA has collaborated with Eli Lilly (LLY) to allow an unidentified 79-year-old man to receive the Indiana-based pharma giant’s next-gen obesity therapy retatrutide, Stat News reported on Tuesday.

Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of the weekly biotech podcast, “The Readout Loud.” You can reach Allison on Signal at AllisonDeAngelis ...

This story is republished from STAT, the health and medicine news site that’s a partner to the Globe. Sign up for STAT’s free Morning Rounds newsletter here. WASHINGTON — Millions of Americans with ...

Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the FDA, industry influence, and the agency’s ability to protect and promote public health.

The European Medicines Agency's Committee for Medicinal Products for Human Use issued a positive opinion for Eli Lilly's cancer drug, Jaypirca. In clinical trials, the healthcare giant's once-daily ...

Pharma companies have been part of the global economy and our health systems for centuries. Novartis can trace its origins back 250 years, while Eli Lilly is celebrating its 150th year and Bayer ...

Eli Lilly, Regeneron, Amneal, Cellares, Fujifilm Biotechnologies, Kriya Therapeutics and Kyowa Kirin are the first companies that will participate in the FDA's PreCheck pilot program, CNBC has learned ...

June 29 (Reuters) - The U.S. Food and Drug Administration on Monday selected Eli Lilly (LLY.N), opens new tab, Regeneron (REGN.O), opens new tab and five other companies for a pilot program to ...